Top compounds associated with response to DEFB107A


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA AT13387 CTRPv2 pan-cancer AAC -0.069 0.1
mRNA MI-2 CTRPv2 pan-cancer AAC -0.08 0.1
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA itraconazole CTRPv2 pan-cancer AAC 0.056 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.1
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.046 0.1
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.063 0.1
mRNA R428 CTRPv2 pan-cancer AAC -0.062 0.1
Download CSV